2-54664622-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBS1_SupportingBS2
The NM_003128.3(SPTBN1):c.6590C>T(p.Ser2197Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003128.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTBN1 | NM_003128.3 | c.6590C>T | p.Ser2197Leu | missense_variant | 33/36 | ENST00000356805.9 | NP_003119.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTBN1 | ENST00000356805.9 | c.6590C>T | p.Ser2197Leu | missense_variant | 33/36 | 1 | NM_003128.3 | ENSP00000349259.4 | ||
SPTBN1 | ENST00000615901.4 | c.6596C>T | p.Ser2199Leu | missense_variant | 35/38 | 5 | ||||
SPTBN1 | ENST00000467371.1 | n.1722C>T | non_coding_transcript_exon_variant | 1/4 | 2 | |||||
SPTBN1-AS2 | ENST00000626206.1 | n.442G>A | non_coding_transcript_exon_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251428Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135888
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461894Hom.: 0 Cov.: 30 AF XY: 0.0000564 AC XY: 41AN XY: 727248
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74346
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.6590C>T (p.S2197L) alteration is located in exon 33 (coding exon 32) of the SPTBN1 gene. This alteration results from a C to T substitution at nucleotide position 6590, causing the serine (S) at amino acid position 2197 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at